These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6106391)

  • 21. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperprolactinaemia - a risperidone side-effect.
    Grahovac T; Ruzić K; Medved P; Pavesić-Radonja A; Dadić-Hero E
    Psychiatr Danub; 2010 Mar; 22(1):120-2. PubMed ID: 20305606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Neurol Clin; 1988 Feb; 6(1):213-23. PubMed ID: 2898095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
    Bock JL; Nelson JC; Gray S; Jatlow PI
    Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatment of psychotic depression.
    Kripke C
    Am Fam Physician; 2006 Jun; 73(11):1935. PubMed ID: 16770922
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
    Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG
    Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report.
    Wassef A; Watson DJ; Morrison P; Bryant S; Flack J
    J Clin Psychopharmacol; 1989 Feb; 9(1):45-8. PubMed ID: 2565347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic drug levels and antipsychotic effects: a difficult correlation; potential advantage of free (or derivative) versus total plasma levels.
    Garver DL
    J Clin Psychopharmacol; 1989 Aug; 9(4):277-81. PubMed ID: 2570087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiopathogenesis and treatment of psychosis.
    Crow TJ; Harrington CA
    Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
    Coryell W; Turner RD; Sherman A
    J Clin Psychopharmacol; 1987 Jun; 7(3):138-42. PubMed ID: 3298326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 34. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful quetiapine therapy in psychotic patients with mood elevation].
    Kecskés I
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):259-63. PubMed ID: 20150663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desipramine plasma levels and therapeutic response.
    Khalid R; Amin MM; Ban TA
    Psychopharmacol Bull; 1978 Jan; 14(1):43-4. PubMed ID: 343150
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C
    Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with desipramine in endogenous and involutional depressions].
    Rodová A; Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):65-6. PubMed ID: 4907396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuroleptic-induced palilalia. A currently undescribed side effect].
    García C
    Nervenarzt; 1990 Nov; 61(11):676-83. PubMed ID: 1981250
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome].
    Dahm JB; Trenckmann U
    Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.